THYROID EYE DISEASE

This study tested a drug called aflibercept, given as an injection near the eye, for people with active thyroid eye disease. The main goal was to see if the treatment is safe and tolerable. Eleven adults with mild to moderate disease activity received three injections over severa…

This study tested a new drug called LASN01 in 41 adults with moderate-to-severe thyroid eye disease (TED). The drug is an antibody that blocks a protein involved in inflammation. The goal was to see if it could reduce eye bulging and other symptoms safely. Participants received e…

This study tested an investigational drug called veligrotug in 188 people with chronic thyroid eye disease, a condition that causes eye bulging and discomfort. The drug works by blocking a specific receptor to reduce inflammation and tissue swelling behind the eyes. The main goal…

This study tested an investigational drug called VRDN-001 in 143 people with thyroid eye disease who did not respond to treatment in earlier studies. The drug aims to reduce eye inflammation and bulging by blocking a specific receptor. Participants received open-label VRDN-001, a…

This study tested a drug called batoclimab in 114 adults with active thyroid eye disease, a condition that causes eye bulging and inflammation. Participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see if the drug could reduce eye b…

This study tested a new drug called VRDN-001 in 231 people with thyroid eye disease, a condition that causes eye bulging and inflammation. The drug works by blocking a specific receptor to reduce swelling. The main goal was to check safety and how well people tolerate the treatme…

This study looked at how safe and tolerable different lengths of treatment with teprotumumab are for adults with thyroid eye disease. 313 participants received the drug for varying durations to see if shorter treatment works as well and reduces side effects. The goal was to find …

This study looked at how well the drug teprotumumab works for thyroid eye disease, a condition that can cause bulging eyes. It involved 5 people in China who received the drug. The main goal was to see if their eye bulging improved by at least 2 millimeters after treatment.

This study tested a new medicine called IBI311 for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 38 adults with either active or inactive disease received different doses of the drug. The main goals were to see if it safely reduces…

This study tested a drug called batoclimab for people with active thyroid eye disease, a condition that causes eye bulging, redness, and swelling. 86 adults with moderate to severe symptoms received weekly injections of either batoclimab or a placebo for 24 weeks. The main goal w…